Shkreli Rubs Salt in KaloBios Pharma (KBIO) Short Sellers' Wounds
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
KaloBios Pharma (KBIO) Could Drop 50% By Early Next Week: Tim Sykes
November 24, 2015 12:46 PM ESTTim Sykes thinks KaloBios Pharma (NASDAQ: KBIO) could drop 50% by early next week, according to the New York... More
KaloBios Pharma (KBIO) Receives NASDAQ Delisting Notice
November 23, 2015 5:46 PM ESTThe NASDAQ Stock Market notified KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), by letter dated November 17, 2015, that the Company is not currently in compliance with Nasdaqs continued listing requirement set forth in Rule 5250(c)(1) of the Nasdaq Listing Rules (the Rules), due to its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 (the 2015 Third Quarter 10-Q) with the Securities and Exchange Commission (the SEC).
Under the Rules, the Company has 60 calendar days from November 17, 2015 to submit a plan to Nasdaq to regain compliance with the Rules. The Company intends to file... More
Cleveland Biolabs (CBLI) Sees Mid-Day Upside on KBIO Comparison
November 23, 2015 12:36 PM ESTCleveland Biolabs (NASDAQ: CBLI) bumps higher mid-day as company is compared to KaloBios Pharma (NASDAQ: KBIO).
... MoreKaloBios Pharma (KBIO) Halted Again on LUDP
November 23, 2015 12:18 PM ESTKaloBios Pharma (NASDAQ: KBIO) is again halted on limit-up, limit-down trading pause. Last up 109.32%
... MoreKaloBios Pharma (KBIO) triggers limit-up, limit-down trading pause
November 23, 2015 12:01 PM ESTKaloBios Pharma (NASDAQ: KBIO) triggers limit-up, limit-down trading pause.
UPDATE - Shares are now above $45 and are up over 150 percent on today's session. The move is staggering when considering that KBIO closed at $.90 as recently as November 13th.
... MoreKaloBios Pharmaceuticals (KBIO) Squeezes Toward $30/Share
November 23, 2015 11:17 AM ESTKaloBios Pharmaceuticals (NASDAQ: KBIO) is pushing toward $30 as shorts are squeezed with a very limited float. The stock was just $0.90 on Nov 13.
... More